Preparation method of parecoxib sodium impurity compound
A parecoxib sodium and compound technology, applied in the field of drug synthesis, can solve the problems of long steps, low product yield, complicated preparation methods, etc., and achieve the effects of short route, high product purity, and high reaction yield
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0057] Sodium 4-(5-methyl-3-phenyloxazol-4-yl)benzenesulfonate (SM-1, 4.02g, 12.5mmol) and CuCl 2 (1.18g, 8.75mmol) was added into acetonitrile (50mL), and the temperature was controlled at 60-65°C to react for 3h. 正己烷 :V 乙酸乙酯 =3:1, 25mL) after recrystallization, the target product I was obtained, with a yield of 94.2% and a purity of 100%.
Embodiment 2
[0059] Sodium 4-(5-methyl-3-phenyloxazol-4-yl)benzenesulfonate (SM-1, 4.02g, 12.5mmol) and CuCl 2 (0.92g, 6.88mmol) was added to 1,4-dioxane (50mL), and the temperature was controlled at 75-80°C to react for 5h. / Butyl acetate system (V 正己烷 :V 乙酸丁酯 =3:1, 25mL) after recrystallization, the target product I was obtained, with a yield of 86.4% and a purity of 99.96%.
Embodiment 3
[0061] Sodium 4-(5-methyl-3-phenyloxazol-4-yl)benzenesulfonate (SM-1, 4.02g, 12.5mmol) and CuCl 2 (0.84g, 6.25mmol) was added to DME (50mL), and the temperature was controlled at 80-85°C for 6h. After the reaction solution was cooled to room temperature, it was filtered. 石油醚 :V 乙酸丁酯 =3:1, 25mL) after recrystallization, the target product I was obtained, with a yield of 82.4% and a purity of 99.97%.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


